Introduction The 2019 Coronavirus disease (COVID-19) has been characterized as a pandemic, representing a serious global public health emergency. Serological tests have been proposed as reliable tools for detecting Coronavirus SARS-CoV-2 antibodies in infected patients, especially for surveillance or epidemiological purposes. The aim of this study is to evaluate the agreement between the IgM/IgG rapid assays, based on lateral flow immunochromatographic assay, and the fully automated 2019-nCoV IgM and IgG, based on chemiluminescence immunoassay. Materials and methods SARS-CoV-2 antibodies were measured with the BIOSYNEX COVID-19 BSS IgM/IgG test (BIOSYNEX, Illkirch-Graffenstaden, France) and the MAGLUMI CLIA (IgM and IgG) (SNIBE – Shenzhen New Industries Biomedical Engineering, Shenzhen, China) in 70 serum samples from patients with PCR-confirmed diagnosis. The strength of the agreement of the two methods was calculated by using the Cohen Kappa index. Results The results showed a good grade of concordance between the two immunoassays with a Cohen’s kappa coefficient of 0.71 (95%CI: 0.54-0.87) for IgG SARS-CoV-2 antibodies and 0.70 (95%CI: 0.53-0.87) for IgM SARS-CoV-2 antibodies. In addition, the rapid assays BIOSYNEX COVID-19 BSS for detecting SARS-CoV-2 antibodies showed a positive likelihood ratio (LR) of 10.63 (95%CI: 2.79-40.57) for IgG and a LR of 6.79 (95%CI: 2.93-15.69) for IgM. Conclusion Our results suggest that the immunochromatographic rapid IgM/IgG test and the chemiluminescence IgM and IgG immunoassay have a good degree of concordance, suggesting that both could be considered as useful tools for epidemiologic surveillance.
【저자키워드】 serological test, antibodies, CLIA, immunochromatography, 【초록키워드】 COVID-19, coronavirus disease, IgG, IgM, coronavirus, pandemic, 2019-nCoV, lateral flow, China, biomedical engineering, immunoassay, SARS-CoV-2 antibodies, Serological tests, Concordance, SARS-CoV-2 antibody, Surveillance, IgM/IgG, chemiluminescence immunoassay, Engineering, Patient, 2019 coronavirus disease, France, automated, immunochromatographic assay, disease, immunochromatographic, chemiluminescence, lateral flow immunochromatographic assay, Epidemiologic surveillance, IgM and IgG, rapid assays, strength, IgG test, Cohen Kappa index, Cohen’s kappa coefficient, epidemiological purposes, IgG SARS-CoV-2 antibodies, IgM SARS-CoV-2 antibodies, infected patients, PCR-confirmed, PCR-confirmed diagnosis, serum samples, Shenzhen, SNIBE, global public health, material, likelihood ratio, positive, serum sample, rapid assay, Result, evaluate, addition, characterized, calculated, representing, were measured, New, BSS, IgG SARS-CoV-2 antibody, 【제목키워드】 IgG, anti-SARS-CoV-2 IgM, immunochromatographic test,